What is the price-to-earnings ratio of medmix?
The price-earnings ratio of medmix is currently 31.92.
medmix P/E 2024
medmix P/E
31.92
Ticker
MEDX.SW
ISIN
CH1129677105
As of Oct 4, 2024, medmix's P/E ratio was 31.92, a 1,016.08% change from the 2.86 P/E ratio recorded in the previous year.
The medmix P/E history
medmix Aktienanalyse
What does medmix do?
The medmix AG is a Swiss company that specializes in the production and distribution of medical products. The company was founded in 1995 and is headquartered in Rapperswil-Jona in the canton of St. Gallen. The company focuses on developing and selling customized products, but has also expanded to manufacturing standardized products. They offer a wide range of high-quality medical products in the fields of surgery, anesthesia, intensive care, pneumology, and endoscopy. The company's business model is based on manufacturing and selling medical products that meet the latest technical standards and highest quality requirements. They prioritize innovation and research to constantly improve and expand their product range. Some of their products include ventilation devices, gas analyzers, respiratory monitoring systems, anesthesia accessories, endoscopes, surgical instruments, and implants. The company places great value on the quality and technical characteristics of their products, regularly testing and developing them for functionality and safety compliance. medmix ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering medmix's P/E Ratio
The Price to Earnings (P/E) Ratio of medmix is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing medmix's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of medmix is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in medmix’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about medmix stock
How has the price-earnings ratio of medmix changed compared to last year?
The price-to-earnings ratio of medmix has increased by 1,016.08% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of medmix high compared to other companies?
Yes, the price-to-earnings ratio of medmix is high compared to other companies.
How does an increase in the price-earnings ratio of medmix affect the company?
An increase in the price-earnings ratio of medmix would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of medmix affect the company?
A decrease in the price-earnings ratio of medmix would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of medmix?
Some factors that influence the price-earnings ratio of medmix are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does medmix pay?
Over the past 12 months, medmix paid a dividend of 0.5 CHF . This corresponds to a dividend yield of about 4.95 %. For the coming 12 months, medmix is expected to pay a dividend of 0.49 CHF.
What is the dividend yield of medmix?
The current dividend yield of medmix is 4.95 %.
When does medmix pay dividends?
medmix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of medmix?
medmix paid dividends every year for the past 5 years.
What is the dividend of medmix?
For the upcoming 12 months, dividends amounting to 0.49 CHF are expected. This corresponds to a dividend yield of 4.86 %.
In which sector is medmix located?
medmix is assigned to the 'Health' sector.
Wann musste ich die Aktien von medmix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of medmix from 4/30/2024 amounting to 0.5 CHF, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.
When did medmix pay the last dividend?
The last dividend was paid out on 4/30/2024.
What was the dividend of medmix in the year 2023?
In the year 2023, medmix distributed 0.5 CHF as dividends.
In which currency does medmix pay out the dividend?
The dividends of medmix are distributed in CHF.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von medmix
Our stock analysis for medmix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of medmix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.